## ## ## ## ## ## ## ## ||||Page| |---|---|---|---| |Trustees'
Report|||1| |Independent
Examiners'||Report|| |Statement
of Financial|Activities||| |Balance Sheet|||| |Notes to the Accounts|||| |Income and Expenditure||Account|10| ## ## ## ## ## ## ## ## ## ## ## ## ## ## |||Note|Restricted|Unrestricted|Total|Prior Period| |---|---|---|---|---|---|---| ||||Funds|Funds|Funds|Total Funds| ||||f|f|f|f| |Incoming
resources||||||| |From generated
funds;
Voluntary
income
Activities for generating
Investment
income|funds|||46,023
15,852|46,023
15,852|8,074
104,097
21,578| |From charitable
activities||||41,861|41,861|67,514| |Total incoming
resources||||103736|103736|201 263| |Resources expended||||||| |Costs ofgenerating
funds;
Costs of generating
funds
Charitable
activities||||36,372
27,662|36,372
27,662|154,369
47,016| |Governance
costs||||2,040|2,040|5,579| |Total resources expended||||66074|66074|206 964| |Net incoming/(outgoing)|resources before transfers|||37,662|37,662|(5,701)| |Transfers||||||| |Gross transfers
between|funds|||||| |Net incoming/(outgoing)
holding
gains and losses|resources before|||37,662|37,662|(5,701)| |Transfers
between
funds||||||| |Holding gains/(losses)-(realised
Gains/(losses)
on investment||and unrealised)
assets||123,258|123,258|69,330| |Net movements
in funds||||160,920|160,920|(75,031)| |Reconciliation
of Funds||||||| |Total funds brought
forward|||32,374|1,105,098|1,137,472|1,212,503| |Total funds carried forward|||32374|1266318|1298392|1137472| ## |||Notes|2021|2020| |---|---|---|---|---| ||||E|E| |FIXEDASSETS||||| |Investments|||893,591|770,333| |Intangible
assets
Tangible assets|||346
893,937|408
770,741| |CURRENT ASSETS||||| |Debtors||4|6,759|12,922| |Cash at bank and|in hand|5|431,778|379,571| ||||438,537|392,493| |CREDITORS||||| |Amounts
falling due within one year||6|34,082|25,762| |NET CURRENT ASSETSI (LIABILITIES)|||404,455|366,731| |TOTAL ASSETS LESS CURRENT LIABILITIES|||1 298 392|1137472| |INCOME FUNDS||||| |Restricted funds||7|32,374|32,374| |Unrestricted
funds|||1,266,018|1,105,098| ||||1 298 392|1 137472| ## ## ## ## ## ## ## ## ## |3.|FIXEDASSETS||2021f|2020f| |---|---|---|---|---| ||Investments|||| ||Market Value at 1st April 2020
Acquisitions
at cost
Disposals at cost
Gains/(losses)
in the period
Unrealised
gains/(losses)
in the period
Market Value at31stMarch 2021||770,333
183,940
(210,465)
10,084
104,726
858,618|839,663
114,393
(49,189)
10,625
~162.866
752,626| ||Cash holding at31st March 2021||34,973
893591|17,707
770333| ||Historical cost at 31st March 2021||610064|626405| ||The Association's
investments
are managed|by Quilter Cheviot Limited.||| ||Intangible
Assets - Website
Cost at 1st April 2020 and 31st March 2021||20 304|20 304| ||Depreciation
at 1st April 2020 and 31st March 2021||20 304|20 304| ||Net BookValue at 31stMarch 2021|||| ||Tangible Assets
Cost at 1st April 2020 and 31st March 2021||1 971|1 971| ||Depreciation
at 1st April 2020
Charge for period||1,564
61|1,492
71| ||Accumulated
depreciation
at 31stMarch 2021||1 625|1 563| ||Net Book Value at 31st March 2021||346|408| |4.|DEBTORS|||| ||Prepayments
and accrued income||6 759|12922| |5.|CASH AT BANK|||| ||Current account||100|100| ||Reserve account||414,820|362,613| ||Astra - Zeneca||13,602|13,602| ||Hamilton
- Fairley
Translational
Award||781
2,475|781
2,475| ||||431 778|379571| |6.|CREDITORS: Amounts
falling due within
Creditors and accrued expenditure|one year|34 082|2~762| |7.|RESTRICTED FUNDS|RESTRICTED FUNDS|Astra-
Zeneca|Total| |---|---|---|---|---| ||Balance|at 1stApril 2020|32,374|32,374| ||Awards|and costs||| ||Balance|at 31st March 2021|32 374|32374| ## ## ## ## |||||Restricted|Unrestricted|Total|Prior Year| |---|---|---|---|---|---|---|---| |Income||||Fundsf|Fundsf|Funds
f.|Total Funds
f| |Voluntary
income
Donations
and Legacies|||||46,023|46,023|8,074| |Activities for generating
funds|||||||| |Response &Resistance|||||||| |3D Model Workshop|||||||| |Student Conference|||||||| |Challenges
preventing
cancer
Tumour microenvironment|cure||||||15,148
47,142.00| |New developments
in breast cancer research|||||||41,807.00| |Investment
income|||||||| |Interest and dividends
receivable|||||15,852|15,852|21,578| |From charitable
activities|||||||| |Subscriptions
Cancer UK contribution
to travel awards|||||46,672
(5,995)|46,672
(5,995)|51,191
16,323| |Provisions
no longer required|||||1,183|1,183|| |Total income|||||103 736|103736|201 263| |Expenditure|||||||| |Costs ofgenerating
funds
BACR conferences|||||560|560|118,594| |Recharged
employee costs
EACR Membership
Printing, postage, stationery,
advertising
Bank and PayPal charges
Depreciation
-fixtures and fittings||and|publications||27,156
7,332
981
312
31|27,156
7,332
981
312
31|25,418
7,766
2,389
166
36| |Charitable
activities|||||||| |Travel awards and bursaries|||||||21,237| |Travel awards and bursaries
(over provided
National
Council for Volunteer
Organisations
Recharged
employee costs
Bank and PayPal charges
Depreciation - fixtures and fittings|||for in 2018)||163
27,156
312
31|163
27,156
312
31|159
25,418
166
36| |Governance costs|||||||| |Committee
and Secretariat travel and other expenses|||||||3,539| |Accountancy|||||2,040
66074|2,040
66074|2,040
206 964| |Surplus/(deficit)
for the year|||||37 662|37662|~5701|